INS and metabolic dysfunction-associated steatotic liver disease: Nowadays, insulin is almost routinely measured in obese patients and in those with FL, and it will be increasingly so if the newly proposed definition of metabolic (dysfunction) associated fatty liver disease (MAFLD) will replace the more traditional separation of FL into non-alcoholic fatty liver disease (NAFLD) and alcoholic fatty liver disease (AFLD) [13].